SSPL Securities Private Limited

Monday 18 Aug, 2025 05:49 PM

Marksans Pharma rises as UK subsidiary gets approval for Metformin Prolonged release tablets Knowledge Marine & Engg jumps on bagging Rs 28-cr order Indostar Capital Finance gains on appointing Amit Kumar Khan as COO Godfrey Phillips India Ltd leads losers in 'A' group Agarwal Industrial Corporation Ltd leads losers in 'B' group Kothari Industrial hits the roof as net loss narrows in Q1 Volumes spurt at K E C International Ltd counter Kwality Pharma secures regulatory approval for anti-cancer drug Bleomycin in Mexico SEPC rises after Q1 PAT spurts 105% YoY to Rs 17 cr Bajaj Finserv Ltd gains for third straight session Bajaj Finance Ltd spurts 6.12% Eicher Motors Ltd up for third straight session TVS Motor Company Ltd soars 6.13%, up for third straight session Ashok Leyland Ltd rises for third consecutive session AU Small Finance Bank Ltd rises for third straight session

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Marksans Pharma rises as UK subsidiary gets approval for Metformin Prolonged release tablets

18-Aug-25 15:45 Hrs IST

The approval was granted by the UK regulatory authorities, allowing Relonchem to market the widely used anti-diabetic medication in three dosage strengths. Metformin is commonly prescribed for the treatment of type 2 diabetes and is considered a frontline therapy for managing blood glucose levels.

Marksans Pharma is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations.

The company's consolidated net profit dropped 34.3% to Rs 58.31 crore despite of 4.97% jump in revenue from operations to Rs 619.98 crore in Q1 FY26 over Q1 FY25.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 43536046

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)